Transdermal Transfersome Nanogels Control Hypertrophic Scar Formation via Synergy of Macrophage Phenotype‐Switching and Anti‐Fibrosis Effect

Yunsheng Chen,Kun Chen,Shan Zhong,Jiaqiang Wang,Zhixi Yu,Xiyang Sun,Yue Wang,Yan Liu,Zheng Zhang

DOI: https://doi.org/10.1002/advs.202305468

IF: 15.1

2023-12-09

Advanced Science

Abstract:Transfersome nanogels (TA/Fu‐TS) realize the transdermal co‐delivery of hydrophobic triamcinolone acetonide and hydrophilic 5‐fluorouracil to macrophages and fibroblasts in emerging hypertrophic scars (HS). Then, TA/Fu‐TSs promote macrophage phenotype‐switching to inhibit inflammation and suppress fibrosis to remodel extracellular matrix. Therefore, TA/Fu‐TSs overcome prolonged inflammation and excessive fibrosis in emerging HS tissues, and provide an effective strategy for controlling HS formation. Hypertrophic scar (HS), which results from prolonged inflammation and excessive fibrosis in re‐epithelialized wounds, is one of the most common clinical challenges. Consequently, sophisticated transdermal transfersome nanogels (TA/Fu‐TS) are prepared to control HS formation by synergistically inhibiting inflammation and suppressing fibrosis. TA/Fu‐TSs have unique structures comprising hydrophobic triamcinolone acetonide (TA) in lipid multilayers and hydrophilic 5‐fluorouracil in aqueous cores, and perform satisfactorily with regard to transdermal co‐delivery to macrophages and HS fibroblasts in emerging HS tissues. According to the in vitro/vivo results, TA/Fu‐TSs not only promote macrophage phenotype‐switching to inhibit inflammation by interleukin‐related pathways, but also suppress fibrosis to remodel extracellular matrix by collagen‐related pathways. Therefore, TA/Fu‐TSs overcome prolonged inflammation and excessive fibrosis in emerging HS tissues, and provide an effective therapeutic strategy for controlling HS formation via their synergy of macrophage phenotype‐switching and anti‐fibrosis effect.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry